Global Precision Medicine Market 2018-2023 - Analysis by Tecehnology, Application and Geography - ResearchAndMarkets.com

DUBLIN--()--The "Global Precision Medicine Market - Segmented by Technology, by Application, Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The precision medicine market is expected to witness a CAGR of 9.7% during the forecast period.

Data from clinical research and other gene sequencing forums are important in understanding the drug targets for personalized medicine. Sharing the information available through online collaborations helps in exchanging useful information between different research groups, thus, increasing online collaborative forums, which is further fuelling the growth of the global precision medicine market.

Additionally, increasing efforts to characterize genes and advancement in cancer biology are also responsible for the growth of the global precision medicine market.

The US precision medicine market accounted for the largest regional share in 2017, owing to high prevalence of cancer, coupled with favorable regulatory scenario in the country. Numerous awareness campaigns and initiatives organized by government and private associations and societies, to increase awareness levels, will propel industry expansion.

For example, the launch of Precision Medicine Initiative (PMI) by President Barack Obama in 2015 for developing innovative solutions for chronic diseases, such as cancer, based on genomic, environment and lifestyle characteristics of patients will also fuel the regional market growth.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities And Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

  • Biocrates Life Sciences AG
  • Nanostring Technologies
  • Intomics
  • Ferrer Incode
  • Pfizer
  • Eagle Genomics Ltd
  • Teva Pharmaceuticals
  • Laboratory Corporation of America Holdings
  • Medtronic
  • Novartis
  • Qiagen
  • Quest Diagnostics
  • Roche Holding AG

10. Future Outlook of the Market

For more information about this report visit https://www.researchandmarkets.com/research/7htlm5/global_precision?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics